Locations:
Min Investment:
Max Investment:
Target Investment:
2008
On going UK and Irish Healthcare Investment Advisor. Board roles include; FIRE1, Microbiotica, ArGEN-X, Kebony, Push Doctor. Notable exits ArGEN-X IPO, BiancaMed acquired by ResMed.
2015
2007
2007
He has worked with several venture capital funds on a variety of assignments since leaving Quester included advising on fund raising, deal origination, due diligence and execution. Currently he is retained by Seventure Partners, a Paris based VC and NESTA, a UK early stage investor.
2008 - 2010
2008 - 2010
Sourced new Healthcare investments and was responsible for the Healthcare portfolio. Notable exits: Sirigen and Dexela. This role was carried out alongside other roles, such as with Seventure and Strategic Advisory Board for Intellectual Property
2005 - 2008
2005 - 2008
1996 - 2007
1996 - 2007
As Deputy Managing Director, He was responsible for all aspects of fund management. Iain founded the Healthcare investment practise and the university linked deal origination platform. When he joined Quester it had under £20m under management and only 4 employees. When Quester was sold in 2007, it had approximately £250m under management and an investment team of 10. Notable exits: Glycart, Vivacta, Sterix, Avidex, Mirada, PowderMed.
1988 - 1995
1988 - 1995
As a Senior Manager in the corporate finance department he gained experience of a wider range of transactions including mergers, acquisitions, IPO's, disposals and insolvency. He also qualified as a tax specialist which helps with the structuring and modeling of many transactions.